STOCK TITAN

Saba discloses 9.99% Sharps Technology (STSS) ownership stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Sharps Technology, Inc. received an updated ownership report showing that funds advised by Saba Capital Management, together with related entities and Boaz R. Weinstein, beneficially own 3,050,450 shares of common stock and warrants, representing 9.99% of the class. The percentage is calculated using 28,995,402 shares outstanding as of December 15, 2025 plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons, as referenced in a recent prospectus.

The reporting group states that the securities are not held for the purpose or effect of changing or influencing control of Sharps Technology and are not part of any control-related transaction, other than activities solely in connection with a board nomination process allowed under relevant rules. Dividends and sale proceeds from these securities are payable to the funds and accounts advised by Saba Capital.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 1,538,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 1,538,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 1,538,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G



Saba Capital Management, L.P.
Signature:/s/ Michael D'Angelo
Name/Title:General Counsel
Date:01/22/2026
Boaz R. Weinstein
Signature:/s/ Michael D'Angelo
Name/Title:Authorized Signatory
Date:01/22/2026
Saba Capital Management GP, LLC
Signature:/s/ Michael D'Angelo
Name/Title:Attorney-in-fact*
Date:01/22/2026

Comments accompanying signature: SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 22, 2026 /s/ Signature Michael D'Angelo Name: Michael D'Angelo Title: General Counsel Boaz R. Weinstein By: Michael D'Angelo Title: Attorney-in-fact*** *** Pursuant to a Power of Attorney dated as of November 16, 2015

FAQ

What ownership stake in Sharps Technology (STSS) does Saba Capital report?

The reporting group led by Saba Capital Management, including related entities and Boaz R. Weinstein, reports beneficial ownership of 3,050,450 shares of Sharps Technology common stock and warrants, representing 9.99% of the class.

How was the 9.99% ownership percentage in Sharps Technology (STSS) calculated?

The 9.99% figure is based on 28,995,402 shares outstanding as of December 15, 2025, as disclosed in a Sharps Technology prospectus, plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons.

Who are the reporting persons in this Sharps Technology (STSS) Schedule 13G/A?

The reporting persons are Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, who have agreed to file jointly under a Joint Filing Agreement dated January 15, 2026.

Does Saba Capital seek to influence control of Sharps Technology (STSS)?

The reporting group certifies that the securities were not acquired and are not held for the purpose or effect of changing or influencing control of Sharps Technology and are not held in connection with any such transaction, other than activities solely in connection with a nomination permitted under Rule 240.14a-11.

Who receives dividends and sale proceeds from the Sharps Technology (STSS) shares held by Saba Capital?

The funds and accounts advised by Saba Capital have the right to receive dividends from, and the proceeds of any sales of, the Sharps Technology common stock reported in this filing.

What type of filing is this Sharps Technology (STSS) document by Saba Capital?

This is an Amendment No. 3 to Schedule 13G, which updates the reporting group’s beneficial ownership of Sharps Technology common stock and related warrants as of the event date January 16, 2026.

Sharps Tech

NASDAQ:STSS

STSS Rankings

STSS Latest News

STSS Latest SEC Filings

STSS Stock Data

63.79M
28.96M
0.08%
0.07%
2.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE